Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel

The survey underscores the substantial underdiagnosis of MASH and the reliance on non-invasive diagnostic methods in Germany. The lack of approved treatments necessitates a focus on lifestyle modifications and comorbidity management. The Delphi panel's insights call for enhanced screening, early detection and standardised algorithms to improve patient outcomes.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2025-07-16
DOI
https://doi.org/10.1111/liv.70225
Citations
5
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
6.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel

Norbert Stefan, Elke Roeb, Heike Bantel, Thomas Ramezani et al.
5 citations
Liver International
Liver Disease Diagnosis and Treatment
6.77
article

Metabolic Dysfunction–Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel

Norbert Stefan, Elke Roeb, Heike Bantel, Thomas Ramezani, Stefan Mauss, Peter Rydqvist, Andreas Geier, Yestle Kim, Karl‐Georg Simon, Wolf Peter Hofmann, Johannes Wiegand, Peter Buggisch, Katja Deterding, Frank Tacke, Jörn M. Schattenberg, Jennifer Scarlet Haas, Anita Pathil
article en
5 citations

Abstract

The survey underscores the substantial underdiagnosis of MASH and the reliance on non-invasive diagnostic methods in Germany. The lack of approved treatments necessitates a focus on lifestyle modifications and comorbidity management. The Delphi panel's insights call for enhanced screening, early detection and standardised algorithms to improve patient outcomes.

Liver InternationalVol. 45(8)
Goethe University Frankfurt (DE), Medizinische Hochschule Hannover (DE), Bayerisches Landesamt für Umwelt (DE), University Hospital and Clinics (US), Ascendis Pharma (Denmark) (DK), Asklepios Klinik St. Georg (DE), University Children's Hospital Tübingen (DE), University Hospital Leipzig (DE), Universitätsklinikum Würzburg (DE), Institute for Interdisciplinary Medicine (DE), University Hospital Frankfurt (DE), Madrigal Pharmaceuticals (United States) (US), Life Science Center Düsseldorf (Germany) (DE), Klinikum Leverkusen (DE), Apocare Pharma (Germany) (DE), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE), Saarland University (DE)
Good health and well-being
Openalex Percentile: Top 3%
Liver Disease Diagnosis and Treatment
6.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.